Persistent colonization of non-lymphoid tissue-resident macrophages by Stenotrophomonas maltophilia.


Journal

International immunology
ISSN: 1460-2377
Titre abrégé: Int Immunol
Pays: England
ID NLM: 8916182

Informations de publication

Date de publication:
07 02 2020
Historique:
received: 24 09 2019
accepted: 17 10 2019
pubmed: 21 10 2019
medline: 2 10 2020
entrez: 21 10 2019
Statut: ppublish

Résumé

Accumulating evidence has revealed that lymphoid tissue-resident commensal bacteria (e.g. Alcaligenes spp.) survive within dendritic cells. We extended our previous study by investigating microbes that persistently colonize colonic macrophages. 16S rRNA-based metagenome analysis using DNA purified from murine colonic macrophages revealed the presence of Stenotrophomonas maltophilia. The in situ intracellular colonization by S. maltophilia was recapitulated in vitro by using bone marrow-derived macrophages (BMDMs). Co-culture of BMDMs with clinically isolated S. maltophilia led to increased mitochondrial respiration and robust IL-10 production. We further identified a 25-kDa protein encoded by the gene assigned as smlt2713 (recently renamed as SMLT_RS12935) and secreted by S. maltophilia as the factor responsible for enhanced IL-10 production by BMDMs. IL-10 production is critical for maintenance of the symbiotic condition, because intracellular colonization by S. maltophilia was impaired in IL-10-deficient BMDMs, and smlt2713-deficient S. maltophilia failed to persistently colonize IL-10-competent BMDMs. These findings indicate a novel commensal network between colonic macrophages and S. maltophilia that is mediated by IL-10 and smlt2713.

Identifiants

pubmed: 31630178
pii: 5601250
doi: 10.1093/intimm/dxz071
pmc: PMC10689348
doi:

Substances chimiques

IL10 protein, mouse 0
Interleukin-10 130068-27-8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-141

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of The Japanese Society for Immunology.

Références

Sci Rep. 2014 Oct 13;4:6602
pubmed: 25308100
Eur J Clin Microbiol Infect Dis. 1996 Jul;15(7):607-10
pubmed: 8874082
Am J Pathol. 1996 May;148(5):1503-15
pubmed: 8623920
Appl Environ Microbiol. 1997 Jul;63(7):2593-9
pubmed: 9212409
mBio. 2017 Oct 17;8(5):
pubmed: 29042502
Science. 2016 Dec 16;354(6318):
pubmed: 27980159
Science. 2012 Jun 8;336(6086):1321-5
pubmed: 22674331
Cell. 2018 Oct 4;175(2):400-415.e13
pubmed: 30173915
Int Immunol. 2010 Dec;22(12):953-62
pubmed: 21051439
Cell. 2009 Oct 30;139(3):485-98
pubmed: 19836068
Infect Immun. 2016 Nov 18;84(12):3313-3327
pubmed: 27600508
Nat Rev Immunol. 2016 May;16(5):295-309
pubmed: 27087661
Nat Rev Immunol. 2010 Mar;10(3):170-81
pubmed: 20154735
Immunity. 2016 Mar 15;44(3):634-646
pubmed: 26982365
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7419-24
pubmed: 20360558
Nat Rev Immunol. 2010 Jun;10(6):415-26
pubmed: 20498668
Nature. 2016 Jul 06;535(7610):75-84
pubmed: 27383982
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):5010-5
pubmed: 22403066
Infect Immun. 2017 Apr 21;85(5):
pubmed: 28264910
Nat Immunol. 2019 Jul;20(7):793-801
pubmed: 31213715
Immunity. 2018 Jul 17;49(1):151-163.e5
pubmed: 29980437
Science. 2017 Aug 25;357(6353):806-810
pubmed: 28775213
Immunity. 2015 Sep 15;43(3):541-53
pubmed: 26320660
Mucosal Immunol. 2018 May;11(3):693-702
pubmed: 29411777
Science. 2014 Jan 10;343(6167):204-8
pubmed: 24408438
Nat Rev Microbiol. 2006 Apr;4(4):295-305
pubmed: 16541137
Annu Rev Immunol. 2017 Apr 26;35:119-147
pubmed: 28125357
J Clin Microbiol. 2007 Feb;45(2):529-35
pubmed: 17135443
Trends Microbiol. 2018 Jul;26(7):637-638
pubmed: 29754971
Clin Microbiol Rev. 2012 Jan;25(1):2-41
pubmed: 22232370

Auteurs

Ichiro Takahashi (I)

Department of Mucosal Immunology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.
Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki-Osaka, Japan.

Koji Hosomi (K)

Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki-Osaka, Japan.

Takahiro Nagatake (T)

Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki-Osaka, Japan.

Hirokazu Toubou (H)

Department of Mucosal Immunology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

Daiki Yamamoto (D)

Department of Mucosal Immunology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

Ikue Hayashi (I)

Department of Mucosal Immunology, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.

Yosuke Kurashima (Y)

International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Shintaro Sato (S)

International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Naoko Shibata (N)

International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Yoshiyuki Goto (Y)

International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Fumito Maruyama (F)

Department of Microbiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Ichiro Nakagawa (I)

Department of Microbiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Asaomi Kuwae (A)

Laboratory of Bacterial Infection, Kitasato Institute for Life Sciences, Kitasato University, Tokyo, Japan.

Akio Abe (A)

Laboratory of Bacterial Infection, Kitasato Institute for Life Sciences, Kitasato University, Tokyo, Japan.

Jun Kunisawa (J)

Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki-Osaka, Japan.
International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Graduate School of Medicine, Graduate School of Pharmaceutical Sciences, and Graduate School of Dentistry, Osaka University, Suita-Osaka, Japan.
Graduate School of Medicine, Kobe University, Kobe-Hyogo, Japan.

Hiroshi Kiyono (H)

International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH